Wednesday, February 8, 2023

Tag: FDA and pharma

FDA Approves Failed Alzheimer’s Drug

2
The FDA approved Biogen's failed drug aducanumab, overriding the 10-0 recommendation of its own advisory committee. Three panel members resigned in protest.

Statisticians: Current Policies Approve Ineffective Treatments

1
Current standards for clinical trials rely on statistical methods that allow for ineffective treatments to gain approval.